Stephen R Fussell Form 4 ABBOTT LABORATORIES / Stephen R Fussell ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Fussell Stephen R

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK IL 60064-6400

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/16/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares without par value	02/16/2018		A		44,909(1)	A	$0	184,884	D
Common shares without par value	02/20/2018		M		104,642	A	$38.4	289,526	D
Common shares without par value	02/20/2018		S		1,100	D	$59.47	288,426	D
Common shares without par value	02/20/2018		S		300	D	$59.48	288,126	D
Common shares without par value	02/20/2018		S		1,419	D	$59.49	286,707	D
Common shares without par value	02/20/2018		S		441	D	$59.495	286,266	D
Common shares without par value	02/20/2018		S		1,200	D	$59.5	285,066	D
Common shares without par value	02/20/2018		S		1,172	D	$59.51	283,894	D
Common shares without par value	02/20/2018		S		200	D	$59.515	283,694	D
Common shares without par value	02/20/2018		S		728	D	$59.52	282,966	D
Common shares without par value	02/20/2018		S		989	D	$59.53	281,977	D
Common shares without par value	02/20/2018		S		226	D	$59.54	281,751	D
Common shares without par value	02/20/2018		S		574	D	$59.545	281,177	D
Common shares without par value	02/20/2018		S		180	D	$59.56	280,997	D
Common shares without par value	02/20/2018		S		500	D	$59.58	280,497	D
Common shares without par value	02/20/2018		S		500	D	$59.585	279,997	D
Common shares without par value	02/20/2018		S		500	D	$59.59	279,497	D
Common shares without par value	02/20/2018		S		100	D	$59.595	279,397	D
Common shares without par value	02/20/2018		S		22,500	D	$59.6	256,897	D
Common shares without par value	02/20/2018		S		1,600	D	$59.63	255,297	D
Common shares without par value	02/20/2018		S		500	D	$59.635	254,797	D
Common shares without par value	02/20/2018		S		1,700	D	$59.64	253,097	D
Common shares without par value	02/20/2018		S		600	D	$59.645	252,497	D
Common shares without par value	02/20/2018		S		4,794	D	$59.65	247,703	D
Common shares without par value	02/20/2018		S		3,200	D	$59.655	244,503	D
Common shares without par value	02/20/2018		S		10	D	$59.6575	244,493	D
Common shares without par value	02/20/2018		S		8,206	D	$59.66	236,287	D
Common shares without par value	02/20/2018		S		2,985	D	$59.665	233,302	D
Common shares without par value	02/20/2018		S		77	D	$59.668	233,225	D
Common shares without par value	02/20/2018		S		100	D	$59.669	233,125	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)(2)	$59.94	02/16/2018		A		246,963		02/16/2019	02/15/2028	Common shares	246,963	$0	246,963	D
Option (right to buy)(3)	$38.4	02/20/2018		M			104,642	02/19/2018	02/18/2026	Common shares	104,642	$0	104,642	D

Explanation of Responses:

1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

2. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 82,321 on 02/16/2019, 82,321 on 02/16/2020, and 82,321 on 02/16/2021.

3. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 1 of 3.

	John A. Berry, by power of attorney for Stephen R. Fussell	02/21/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.